Literature DB >> 24274867

The role of diet and nutritional intervention for the management of patients with NAFLD.

Francisco Barrera1, Jacob George.   

Abstract

During the last few decades, the prevalence of obesity, insulin resistance and non-alcoholic fatty liver disease (NAFLD) have dramatically increased. Nutrition and modern lifestyle habits are intimately involved in this epidemiological change. Although lifestyle intervention can theoretically revert the metabolic disturbances and prevent the long term complications of NAFLD, its efficacy is diminished in clinical practice by poor implementation and reduced adherence to lifestyle intervention programs. In this article we summarize the main elements of dietary interventions for NAFLD, describe practical strategies to optimize efficacy and review potential nutritional strategies under development that hopefully will improve outcomes in the future.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Insulin resistance; Lifestyle intervention; Macronutrients; Mediterranean diet; Nonalcoholic fatty liver; Steatohepatitis; Weight loss

Mesh:

Year:  2013        PMID: 24274867     DOI: 10.1016/j.cld.2013.09.009

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  38 in total

1.  Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.

Authors:  Robert J Pattison; James Phillip Esteban; Tomoki Sempokuya; Jakrin Kewcharoen; Sumodh Kalathil; Scott K Kuwada
Journal:  Hawaii J Health Soc Welf       Date:  2020-06-01

Review 2.  Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.

Authors:  William N Hannah; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2016-05       Impact factor: 3.199

3.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  Diabetologia       Date:  2016-06       Impact factor: 10.122

4.  Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease.

Authors:  Narges Damavandi; Sirous Zeinali
Journal:  Mol Biol Rep       Date:  2021-01-25       Impact factor: 2.316

5.  Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).

Authors:  Giada Sebastiani; Keyur Patel; Vlad Ratziu; Jordan J Feld; Brent A Neuschwander-Tetri; Massimo Pinzani; Salvatore Petta; Annalisa Berzigotti; Peter Metrakos; Naglaa Shoukry; Elizabeth M Brunt; An Tang; Jeremy F Cobbold; Jean-Marie Ekoe; Karen Seto; Peter Ghali; Stéphanie Chevalier; Quentin M Anstee; Heather Watson; Harpreet Bajaj; James Stone; Mark G Swain; Alnoor Ramji
Journal:  Can Liver J       Date:  2022-02-04

6.  Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.

Authors:  Sajan Jiv Singh Nagpal; Mohammad Nasser Kabbany; Bashar Mohamad; Rocio Lopez; Nizar N Zein; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

Review 7.  Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

Authors:  Vikas Gupta; Xian-Jun Mah; Maria Carmela Garcia; Christina Antonypillai; David van der Poorten
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

8.  Assessing Interactions between PNPLA3 and Dietary Intake on Liver Steatosis in Mexican-Origin Adults.

Authors:  Kristin E Morrill; Victoria L Bland; Yann C Klimentidis; Melanie D Hingle; Cynthia A Thomson; David O Garcia
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 4.614

Review 9.  NAFLD and cardiovascular diseases: a clinical review.

Authors:  Philipp Kasper; Anna Martin; Sonja Lang; Fabian Kütting; Tobias Goeser; Münevver Demir; Hans-Michael Steffen
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460

10.  Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts.

Authors:  Sreepradha Eswaran; Anshu Babbar; Hannah K Drescher; Thomas C A Hitch; Thomas Clavel; Moritz Muschaweck; Thomas Ritz; Daniela C Kroy; Christian Trautwein; Norbert Wagner; Angela Schippers
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.